Eli Lilly CEO David Ricks on Covid antibody treatment’s effectiveness against mutations

Eli Lilly CEO David Ricks on Covid antibody treatment’s effectiveness against mutations

Eli Lilly CEO David Ricks says pre-clinical data that suggests the company’s antibody treatment will be effective against the coronavirus variant found in the United Kingdom. He does say there is some concern that the treatment will not be as effective against the Japanese strain of the virus.

More News Stories

Loading...

More Political News

Loading...